COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

31,284 Articles (22,759 medRxiv, 8,525 bioRxiv)

Most recent first Previous |  Page 1695: Articles 16941-16950  | Next

Structural modeling of the SARS-CoV-2 Spike/human ACE2 complex interface can identify high-affinity variants associated with increased transmissibility
Gan, H. H., Twaddle, A., Marchand, B., Gunsalus, K.
10.1101/2021.03.22.436454 — Posted: 2021-03-22
Live imaging of SARS-CoV-2 infection in mice reveals neutralizing antibodies require Fc function for optimal efficacy
Ullah, I., Prevost, J., Ladinsky, M. S., Stone, H., Lu, M., Anand, S. P., Beaudoin-Bussieres, G., Benlarbi, M., Ding, S., Gasser, R., Fink, C., Chen, Y., Tauzin, A., Goyette, G., Bourassa, C., Medjahed, H., Mack, M., Chung, K., Wilen, C. B., Dekaban, G. A., Dikeakos, J. D., Bruce, E. A., Kaufmann, D. E., Stamatatos, L., McGuire, A., Richard, J., Pazgier, M., Bjorkman, P., Mothes, W., Finzi, A., Kumar, P., Uchil, P. D.
10.1101/2021.03.22.436337 — Posted: 2021-03-22
Predicting hosts based on early SARS-CoV-2 samples and analyzing later world-wide pandemic in 2020
Guo, Q., Li, M., Wang, C., Guo, J., Jiang, X., Tan, J., Wu, S., Wang, P., Xiao, T., Zhou, M., Fang, Z., Xiao, Y., Zhu, H.
10.1101/2021.03.21.436312 — Posted: 2021-03-22
An mRNA vaccine against SARS-CoV-2: Lyophilized, liposome-based vaccine candidate EG-COVID induces high levels of virus neutralizing antibodies
Kim, S.-H., Cho, Y. J., Hong, H. C., Kim, K. S., Park, S. A., Chun, M. J., Hong, E. Y., Chung, S. W., Kim, H. J., Shin, B. G.
10.1101/2021.03.22.436375 — Posted: 2021-03-22
CVnCoV protects human ACE2 transgenic mice from ancestral B BavPat1 and emerging B.1.351 SARS-CoV-2
Hoffmann, D., Corleis, B., Rauch, S., Roth, N., Muehe, J., Halwe, N. J., Ulrich, L., Fricke, C., Schoen, J., Kraft, A., Breithaupt, A., Wernike, K., Michelitsch, A., Sick, F., Wylezich, C., Mueller, S. O., Mettenleiter, T. C., Petsch, B., Dorhoi, A., Beer, M.
10.1101/2021.03.22.435960 — Posted: 2021-03-22 Discussion: Onsite
Protease-activatable biosensors of SARS-CoV-2 infection for cell-based drug, neutralisation and virological assays
Pereyra Gerber, P., Duncan, L. M., Greenwood, E. J., Marelli, S., Naamati, A., Teixeira-Silva, A., Crozier, T. W., Gabaev, I., Zhan, J. R., Protasio, A. V., Matheson, N. J.
10.1101/2021.03.22.435957 — Posted: 2021-03-22
Network medicine links SARS-CoV-2/COVID-19 infection to brain microvascular injury and neuroinflammation in dementia-like cognitive impairment
Zhou, Y., Xu, J., Hou, Y., Leverenz, J. B., Kallianpur, A., Mehra, R., Liu, Y., Yu, H., Pieper, A. A., Jehi, L., Cheng, F.
10.1101/2021.03.15.435423 — Posted: 2021-03-22
Role of Combining Anticoagulant and Antiplatelet Agents in COVID-19 Treatment: A Rapid Review
Matli, K., Farah, R., Maalouf, M., Costanian, C., Chamoun, N., Ghanem, G.
10.1101/2021.03.21.21253754 — Posted: 2021-03-22
Symptoms of COVID-19 in a population-based cohort study
Khan, S. M., Farland, L. V., Austhof, E., Bell, M. L., Catalfamo, C. J., Chen, Z., Cordova-Marks, F., Ernst, K. C., Garcia-Filion, P., Heslin, K. M., Hoskinson, J., Jehn, M. L., Joseph, E. C. S., Kelley, C. P., Klimentidis, Y., Carrol, S., Kohler, L. N., Pogreba-Brown, K., Jacobs, E. T.
10.1101/2021.03.20.21254040 — Posted: 2021-03-22
Vascular Inflammation in Lungs of Patients with Fatal Coronavirus Disease 2019 (COVID-19) Infection: Possible role for the NLRP3 inflammasome
Paul, O., Tao, J. Q., Litzky, L., Feldman, M., Montone, K., Rajapakse, C., Bermudez, C., Chatterjee, S.
10.1101/2021.03.19.21253815 — Posted: 2021-03-22

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).